Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 open-label single-arm study of single-dose GS1191-0445 in Chinese adults with hemophilia A
CTR20250365Phase 3Active
- Sponsor
- Huayi Lejian
- Start
- Feb 2025
- Modality
- Gene Therapies
- Countries
- 1
01
Overview
A Phase 3 trial of GS001 in hemophilia A, sponsored by Huayi Lejian. Started Feb 2025; status: active.
02
Drugs
GS001
03
Conditions
hemophilia A
Beyond the preview
Go deeper on CTR20250365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20250365.